16歳以上の部分発作患者（二次性全般化発作の有無を問わず）における補助療法としてブリバラセタム（BRV）を使用した場合の安全性と有効性を検証する研究

基本情報

NCT ID: NCT03250377
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 207
治験依頼者名: UCB Pharma

概要

The purpose of the study is to evaluate the long-term safety and tolerability of Brivaracetam (BRV) in focal epilepsy subjects with partial seizures and to evaluate the maintenance of efficacy of BRV over time.

対象疾患

Partial Seizures With or Without Secondary GeneralizationEpilepsy

介入

Brivaracetam(DRUG)

依頼者（Sponsor）

ユーシービージャパン(INDUSTRY)

実施施設 (40)

Ep0085 105

Nagakute, Japan

Ep0085 103

Sendai, Japan

Ep0085 110

Hiroshima, Japan

Ep0085 140

Kawasaki, Japan

Ep0085 118

Nagoya, Japan

Ep0085 138

Tsukuba, Japan

Ep0085 128

Kurume, Japan

Ep0085 121

Itami, Japan

Ep0085 129

Neyagawa, Japan

Ep0085 122

Hachinohe, Japan

Ep0085 133

Ushiku, Japan

Ep0085 109

Yamagata, Japan

Ep0085 130

Ôsaka, Japan

Ep0085 141

Higashisonogi-gun Kawatana-cho, Japan

Ep0085 104

Shizuoka, Japan

Ep0085 114

Saitama, Japan

Ep0085 123

Kodaira, Japan

Ep0085 127

Bunkyō City, Japan

Ep0085 102

Kagoshima, Japan

Ep0085 124

Kyoto, Japan

Ep0085 132

Kōriyama, Japan

Ep0085 150

Yokohama, Japan

Ep0085 136

Nagoya, Japan

Ep0085 142

Kamakura, Japan

Ep0085 148

Adachi-ku, Japan

Ep0085 144

Shinjuku-ku, Japan

Ep0085 112

Kōshi, Japan

Ep0085 120

Yokohama, Japan

Ep0085 101

Sapporo, Japan

Ep0085 115

Kokubunji, Japan

Ep0085 147

Kyoto, Japan

Ep0085 116

Asaka, Japan

Ep0085 108

Suita, Japan

Ep0085 111

Hamamatsu, Japan

Ep0085 137

Suita, Japan

Ep0085 106

Niigata, Japan

Ep0085 131

Ōtsu, Japan

Ep0085 850

Osaka, Japan

Ep0085 126

Bunkyō City, Japan

Ep0085 117

Nara, Japan